Skip to main content
. 2021 Mar 11;134(11):1317–1323. doi: 10.1097/CM9.0000000000001407

Figure 2.

Figure 2

Comparison of baseline characteristics between EMPA-REG OUTCOME trial population and eligible inpatient and outpatient adults with diabetes. MCID: Minimally clinically important difference; HbA1c: Glycated hemoglobin A1c; eGFR: Estimated glomerular filtration rate; LDL-c: Low-density lipoprotein cholesterol; HDL-c: High-density lipoprotein cholesterol; TG: Triglycerides; TC: Total cholesterol; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; UACR: Urine albumin-to-creatinine ratio; ACEI: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin receptor blocker. The percentage difference is equal to the percentage in the EMPA-REG OUTCOME trial population minus that in each identified population. The mean difference is equal to the mean in the EMPA-REG OUTCOME trial population minus that in each identified population. Standardized MCID = MCID/MCID×100%. Standardized mean difference = mean difference/its MCID × 100%.